IDXX · 8-K · 20260804PR090033

Operating Expense Trends

IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 46 · Surprise 22

Second-quarter operating expenses increased 10% reported and 9% on a comparable basis to $353.5 million from $321.7 million. Sales and marketing expense rose to $171.3 million from $161.1 million, while general and administrative expense increased to $116.8 million from $98.7 million. Research and development expense increased to $65.4 million from $61.9 million, although R&D declined to 5.4% of revenue from 5.6%. The spending supported expanded commercial capabilities, innovation initiatives, and information technology investments.

Key facts

• Operating expense for Q2 2026: $353,521, a 10% operating expense increase as reported and 9% growth on a comparable basis. source